p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models
Urologic Oncology: Seminars and Original Investigations | Dec 14, 2017